Skip to content

Development of the self-efficacy questionnaire for insulin users (Study)

Development of the self-efficacy questionnaire for insulin users (Study) - Development of the self-efficacy questionnaire for insulin users (Study) [THE SELF-EFFICACY-Q Study]

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020062
Enrollment
236
Registered
2015-12-03
Start date
2015-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 and Type 2 diabetes

Interventions

None listed

Sponsors

Japan Society for Patient Reported Outcome (PRO)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are included in this study. 1. Out-patients who has been on insulin treatment for 12 weeks or longer (either type 1 or type 2 diabetes) 2. Male or female who is 20 years of age or older at the point of giving written consent 3. Patients who can provided written consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients who fall into any of the following criteria are excluded from participating in the study. 1. Currently have psychological disorders, dementia, or dementia-like symptoms 2. Incapable of making judgement for themselves 3. Need a proxy to make any important judgement for them 4. Other conditions considered to be unsuitable by the attending physician

Design outcomes

Primary

MeasureTime frame
* Evaluation of the new self-efficacy questionnaire (validity and reliability) * Evaluation of correlations between the new self-efficacy questionnaire and other questionnaires (DTSQ, PAID)

Countries

Japan

Contacts

Public ContactHiroki Takayama

Soiken Inc. Clinical Study Support Division

takayama@soiken.com03-3295-1350

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026